Weiner LM - Search Results

1

A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.

Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ. Denlinger CS, et al. Among authors: weiner lm. Clin Colorectal Cancer. 2014 Jun;13(2):81-6. doi: 10.1016/j.clcc.2013.12.005. Epub 2014 Jan 4. Clin Colorectal Cancer. 2014. PMID: 24512954 Free PMC article. Clinical Trial.

2

Treatment of advanced measurable or evaluable pancreatic carcinoma with 17-1A murine monoclonal antibody alone or in combination with 5-fluorouracil, adriamycin and mitomycin (FAM).

Paul AR, Engstrom PF, Weiner LM, Steplewski Z, Koprowski H. Paul AR, et al. Among authors: weiner lm. Hybridoma. 1986 Jul;5 Suppl 1:S171-4. Hybridoma. 1986. PMID: 3527946 Clinical Trial.

3

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK. Weiner LM, et al. Cancer Res. 1995 Oct 15;55(20):4586-93. Cancer Res. 1995. PMID: 7553634 Clinical Trial.

4

CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor.

Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, McCord MC, Minasian L, Alpaugh RK, Weiner LM, Munn DH. Saleh MN, et al. Among authors: weiner lm. Blood. 1995 May 15;85(10):2910-7. Blood. 1995. PMID: 7742551 Free article. Clinical Trial.

5

Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.

Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Algan O, et al. Among authors: weiner lm. Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):753-61. doi: 10.1016/0360-3016(94)00592-9. Int J Radiat Oncol Biol Phys. 1995. PMID: 7790262 Clinical Trial.

6

Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinoma.

Langer CJ, Catalano R, Weiner LM, Scher R, Bagchi P, Saren B, Comis RL. Langer CJ, et al. Among authors: weiner lm. Cancer Invest. 1995;13(2):150-9. doi: 10.3109/07357909509011684. Cancer Invest. 1995. PMID: 7874568 Clinical Trial.

7

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Weiner LM, et al. Cancer Res. 1994 Aug 1;54(15):4084-90. Cancer Res. 1994. PMID: 8033141 Clinical Trial.

8

Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1.

Weiner LM, Holmes M, Richeson A, Godwin A, Adams GP, Hsieh-Ma ST, Ring DB, Alpaugh RK. Weiner LM, et al. J Immunol. 1993 Sep 1;151(5):2877-86. J Immunol. 1993. PMID: 8103070

9

Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.

Amoroso AR, Clark JI, Litwin S, Hsieh-Ma S, Shi T, Alpaugh RK, Adams GP, Wolf EJ, Ring DB, Weiner LM. Amoroso AR, et al. Among authors: weiner lm. Cancer Res. 1996 Jan 1;56(1):113-20. Cancer Res. 1996. PMID: 8548750

10

Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Ring DB, Alpaugh RK. Weiner LM, et al. J Hematother. 1995 Oct;4(5):453-6. doi: 10.1089/scd.1.1995.4.453. J Hematother. 1995. PMID: 8581384 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters